Marker Therapeutics Inc (MRKR)

Currency in USD
1.350
-0.070(-4.93%)
Closed·
1.370+0.020(+1.48%)
·
MRKR is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.3501.440
52 wk Range
0.8104.070
Key Statistics
Prev. Close
1.35
Open
1.42
Day's Range
1.35-1.44
52 wk Range
0.81-4.07
Volume
173.86K
Average Volume (3m)
274.49K
1-Year Change
-60.53%
Book Value / Share
1.42
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MRKR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.333
Upside
+443.21%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Marker Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Marker Therapeutics Inc Company Profile

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.

Compare MRKR to Peers and Sector

Metrics to compare
MRKR
Peers
Sector
Relationship
P/E Ratio
−1.6x−3.8x−0.6x
PEG Ratio
0.54−0.130.00
Price/Book
1.2x2.4x2.6x
Price / LTM Sales
4.8x16.6x3.2x
Upside (Analyst Target)
-66.7%41.8%
Fair Value Upside
Unlock3.1%5.1%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.333
(+443.21% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
H.C. Wainwright
Buy10.00+640.74%-MaintainDec 08, 2025
Canaccord Genuity
Buy8.00+492.59%-New CoverageMar 05, 2025
Brookline Capital Markets
Buy4.00+196.30%-New CoverageFeb 11, 2025

Earnings

Latest Release
Nov 13, 2025
EPS / Forecast
-0.12 / -0.62
Revenue / Forecast
1.23M / --
EPS Revisions
Last 90 days

MRKR Income Statement

People Also Watch

1.520
ELDN
-7.32%
0.116
APLT
-7.99%
1.160
KTTA
-1.69%
2.740
BEAT
-6.48%

FAQ

What Is the Marker Therapeutics (MRKR) Stock Price Today?

The Marker Therapeutics stock price today is 1.350

What Stock Exchange Does Marker Therapeutics Trade On?

Marker Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Marker Therapeutics?

The stock symbol for Marker Therapeutics is "MRKR."

What Is the Marker Therapeutics Market Cap?

As of today, Marker Therapeutics market cap is 22.51M.

What Is Marker Therapeutics's Earnings Per Share (TTM)?

The Marker Therapeutics EPS (TTM) is -1.12.

From a Technical Analysis Perspective, Is MRKR a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Marker Therapeutics Stock Split?

Marker Therapeutics has split 5 times.

How Many Employees Does Marker Therapeutics Have?

Marker Therapeutics has 5 employees.

What is the current trading status of Marker Therapeutics (MRKR)?

As of Dec 24, 2025, Marker Therapeutics (MRKR) is trading at a price of 1.350, with a previous close of 1.350. The stock has fluctuated within a day range of 1.350 to 1.440, while its 52-week range spans from 0.810 to 4.070.

What Is Marker Therapeutics (MRKR) Price Target According to Analysts?

The average 12-month price target for Marker Therapeutics is USD7.33333, with a high estimate of USD10 and a low estimate of USD4. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +443.21% Upside potential.

What Is the MRKR After Hours Price?

MRKR's last after hours stock price is 1.370, the stock has decreased by 0.020, or 1.480%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.